EFFECTS OF MESO-2,3-DIMERCAPTOSUCCINIC ACID (DMSA) ON THE TERATOGENICITY OF SODIUM ARSENATE IN MICE

被引:9
作者
BOSQUE, MA
DOMINGO, JL
LLOBET, JM
CORBELLA, J
机构
[1] UNIV BARCELONA,SCH MED,TOXICOL & BIOCHEM LAB,SAN LORENZO 21,E-43201 REUS,SPAIN
[2] UNIV BARCELONA,SCH MED,DEPT TOXICOL,E-08036 BARCELONA,SPAIN
关键词
D O I
10.1007/BF01701134
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
[No abstract available]
引用
收藏
页码:682 / 688
页数:7
相关论文
共 22 条
  • [1] DMSA AND DMPS - WATER-SOLUBLE ANTIDOTES FOR HEAVY-METAL POISONING
    APOSHIAN, HV
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1983, 23 : 193 - 215
  • [2] APOSHIAN HV, 1990, ANNU REV PHARMACOL, V30, P279
  • [3] PRENATAL TOXICITY OF ORALLY-ADMINISTERED SODIUM ARSENITE IN MICE
    BAXLEY, MN
    HOOD, RD
    VEDEL, GC
    HARRISON, WP
    SZCZECH, GM
    [J]. BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY, 1981, 26 (06) : 749 - 756
  • [4] BEAUDOIN AR, 1974, TERATOLOGY, V10, P153, DOI 10.1002/tera.1420100211
  • [5] EMBRYOTOXIC EFFECTS OF SODIUM ARSENITE AND SODIUM ARSENATE ON MOUSE EMBRYOS IN CULTURE
    CHAINEAU, E
    BINET, S
    POL, D
    CHATELLIER, G
    MEININGER, V
    [J]. TERATOLOGY, 1990, 41 (01) : 105 - 112
  • [6] DEVELOPMENTAL TOXICITY OF SUBCUTANEOUSLY ADMINISTERED MESO-2,3-DIMERCAPTOSUCCINIC ACID IN MICE
    DOMINGO, JL
    PATERNAIN, JL
    LLOBET, JM
    CORBELLA, J
    [J]. FUNDAMENTAL AND APPLIED TOXICOLOGY, 1988, 11 (04): : 715 - 722
  • [7] FERM VH, 1968, J REPROD FERTIL, V17, P199
  • [8] TRANSFER OF ANTIMONY AND ARSENIC TO THE DEVELOPING ORGANISM
    GERBER, GB
    MAES, J
    EYKENS, B
    [J]. ARCHIVES OF TOXICOLOGY, 1982, 49 (02) : 159 - 168
  • [9] POLYNEUROPATHY DUE TO ACUTE ARSENIC INTOXICATION - BIOPSY STUDIES
    GOEBEL, HH
    SCHMIDT, PF
    BOHL, J
    TETTENBORN, B
    KRAMER, G
    GUTMANN, L
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1990, 49 (02) : 137 - 149
  • [10] ROLE OF 2,3-DIMERCAPTOSUCCINIC ACID IN THE TREATMENT OF HEAVY-METAL POISONING
    GRAZIANO, JH
    [J]. MEDICAL TOXICOLOGY AND ADVERSE DRUG EXPERIENCE, 1986, 1 (03): : 155 - 162